TCF3 and Burkitt lymphoma: Initial evidence for BCR involvement in BL lymphomagenesis came from the study of Schmitz and colleagues, who reported recurrent mutations in the transcription factor TCF3/E2A and its negative regulator ID3 in 70% of sporadic BL tumors [108].